Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice

Introduction  Phase 3 trials have shown comparable efficacy of direct oral anticoagulants (DOACs) and vitamin K antagonists in patients with acute venous thromboembolism (VTE), with less major bleeding events in patients randomized to DOAC treatment. With DOACs being increasingly used in clinical pr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:TH Open
Egile Nagusiak: Hendriks, Stephan V., Klok, Frederikus A., Stenger, Wilhelmina J.E., Mairuhu, Albert T.A., Eikenboom, Jeroen, Fogteloo, Jaap, Huisman, Menno V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Georg Thieme Verlag KG 2020
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314657/
https://ncbi.nlm.nih.gov/pubmed/32607465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1713683
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak